Search results for "Drug Compounding"

showing 10 items of 90 documents

Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin.

2011

The ability of a recently developed novel class of liposomes to promote dermal delivery of tretinoin (TRA) was evaluated. New penetration enhancer-containing vesicles (PEVs) were prepared adding to conventional phosphatidylcholine vesicles (control liposomes) different hydrophilic penetration enhancers: Oramix® NS10 (OrNS10), Labrasol® (Lab), Transcutol® P (Trc), and propylene glycol (PG). Vesicles were characterized by morphology, size distribution, zeta potential, incorporation efficiency, stability, rheological behaviour, and deformability. Small, negatively charged, non-deformable, multilamellar vesicles were obtained. Rheological studies showed that PEVs had fluidity higher than conven…

Chemical PhenomenaStereochemistryDrug CompoundingSus scrofaPharmaceutical ScienceTretinoinAdministration CutaneousPermeabilityGlyceridesDiffusionchemistry.chemical_compoundGlucosidesPhosphatidylcholineZeta potentialAnimalsMicroparticleOrganic ChemicalsTransdermalSkinLiposomeDrug CarriersViscosityVesiclefungiPenetration (firestop)PermeationchemistryAnimals NewbornLiposomesBiophysicsEthylene GlycolsPharmaceutical VehiclesRheologyDialysisHydrophobic and Hydrophilic InteractionsInternational journal of pharmaceutics
researchProduct

Impact of uncharged and charged stabilizers on in vitro drug performances of clarithromycin nanocrystals

2018

The purpose of this study was to evaluate the effect of charge on the in vitro drug performances of clarithromycin nanocrystals. To prepare different charges of nanocrystals, media milling was employed with the use of different stabilizing systems. The uncharged nanocrystals were prepared from poloxamer 407. The negatively and positively charged nanocrystals were stabilized using a combination of poloxamer 407 with sodium lauryl sulfate (SLS) and cetyltrimethylammonium bromide (CTAB), respectively. After production, the particle size of the negatively and positively charged nanocrystals was smaller than that of the uncharged one. The similar particle size of variously charged clarithromycin…

Chemistry PharmaceuticalDrug CompoundingPharmaceutical SciencePoloxamer02 engineering and technology030226 pharmacology & pharmacyCell LineExcipients03 medical and health scienceschemistry.chemical_compound0302 clinical medicineBromideClarithromycinMonolayermedicineHumansSurface chargeParticle SizeSolubilityDissolutionCetrimoniumChemistrySodium Dodecyl SulfateBiological TransportGeneral Medicine021001 nanoscience & nanotechnologyAnti-Bacterial AgentsDrug LiberationSolubilityChemical engineeringNanocrystalPoloxamer 407NanoparticlesParticle sizeCaco-2 Cells0210 nano-technologyBiotechnologymedicine.drugEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

Novel insights into excipient effects on the biopharmaceutics of APIs from different BCS classes: Lactose in solid oral dosage forms

2014

Excipients encompass a wide range of properties that are of importance for the resulting drug product. Regulatory guidelines on biowaivers for immediate release formulations require an in depth understanding of the biopharmaceutic effects of excipients in order to establish bioequivalence between two different products carrying the same API based on dissolution tests alone. This paper describes a new approach in evaluating biopharmaceutic excipient effects. Actually used quantities of a model excipient, lactose, formulated in combination with APIs from different BCS classes were evaluated. The results suggest that companies use different (relative) amounts depending on the characteristics o…

ChromatographyDrug CompoundingBiopharmaceuticsAdministration OralPharmaceutical ScienceExcipientLactoseBioequivalenceQuality by DesignDosage formBiopharmaceuticsExcipientschemistry.chemical_compoundchemistrymedicineHumansDrug productImmediate releaseLactosemedicine.drugEuropean Journal of Pharmaceutical Sciences
researchProduct

Inhalable nano into micro dry powders for ivacaftor delivery: The role of mannitol and cysteamine as mucus-active agents.

2020

In this paper the innovative approach of Nano into micro (NiM9 was developed to produce Nanoparticles loaded Ivacaftor to incorporate into mannitol or mannitol/cysteamine micromatrices for drug pulmonary administration in CF. Nanoparticles composed by a mixture of two polyhydrohydroxyethtylaspartamide copolymers containing a loading of Ivacaftor of 15.5 % w/w were produced. These Nanoparticles were incorporated into microparticles to obtain NiM that were characterized in terms of size and size distribution, interaction with CF-AM by rheological and turbidimetric studies as well as by aerodynamic diameter measurements. Finally the activity of Ivacaftor into these NiM was evaluated by in vitr…

Cystic Fibrosisαβ-poly-(N-2-hydroxyethyl)-DL-aspartamide (PHEA) copolymer PHEA ivacaftor mucus-penetrating nanoparticle cell penetrating peptide nano into micro strategy. CysteamineDrug CompoundingPharmaceutical ScienceNanoparticleCystic Fibrosis Transmembrane Conductance Regulator02 engineering and technologyQuinolonesAminophenols030226 pharmacology & pharmacyIvacaftor03 medical and health scienceschemistry.chemical_compound0302 clinical medicineNano-Administration InhalationMucus-penetrating nanoparticlemedicineCopolymerAnimalsMannitolChloride Channel AgonistsCells CulturedExpectorantsCell penetrating peptideNano into micro strategyChemistry021001 nanoscience & nanotechnologyMucusRats Inbred F344IvacaftorCopolymer PHEADrug LiberationSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoMutationNanoparticlesCysteamineMannitolPowders0210 nano-technologyPeptidesαβ-poly-(N-2-hydroxyethyl)-DL-aspartamide (PHEA)medicine.drugNuclear chemistryInternational journal of pharmaceutics
researchProduct

Halloysite nanotubes for efficient loading, stabilization and controlled release of insulin

2018

Hypothesis: Oral insulin administration is not actually effective due to insulin rapid degradation, inactivation and digestion by proteolytic enzymes which results in low bioavailability. Moreover insulin is poorly permeable and lack of lipophilicity. These limits can be overcome by the loading of protein in some nanostructured carrier such as halloysite nanotubes (HNTs). Experiments: Herein we propose an easy strategy to obtain HNT hybrid materials for the delivery of insulin. We report a detailed description on the thermal behavior and stability of insulin loaded and released from the HNTs hybrid by the combination of several techniques. Findings: Release experiments of insulin from the H…

Dichroismmedicine.medical_treatmentHalloysite nanotube02 engineering and technology01 natural sciencesBiochemistryNanocompositesChitosanchemistry.chemical_compoundColloid and Surface ChemistryDrug StabilityProtein stabilityHalloysite nanotube (HNTs)InsulinTransdermalSettore CHIM/02 - Chimica FisicaDrug CarriersNanotubesProteolytic enzymes021001 nanoscience & nanotechnologyControlled releaseSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsEnzyme inhibitionAluminum SilicatesBionanocomposite film0210 nano-technologyHybrid materialBionanocomposite hybridSurface PropertiesDrug Compoundingengineering.materialCircular dichroism data010402 general chemistrySustained release InsulinAdministration CutaneousHalloysiteBiomaterialsKaolinitemedicineParticle SizeHybrid materialChitosanInsulinBiomedical applicationMedical applicationYarn Bio-nanocompositeMembranes Artificial0104 chemical sciencesNanotubeDrug LiberationHalloysite nanotubes Insulin Protein stability Sustained release Bionanocomposite hybridchemistryChemical engineeringDelayed-Action PreparationsengineeringClayNanocarriersSustained release
researchProduct

Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: Liposomes, ethosomes and PEVs

2013

Diclofenac-loaded phospholipid vesicles, namely conventional liposomes, ethosomes and PEVs (penetration enhancer-containing vesicles) were developed and their efficacy in TPA (phorbol ester) induced skin inflammation was examined. Vesicles were made from a cheap and unpurified mixture of phospholipids and diclofenac sodium; Transcutol P and propylene glycol were added to obtain PEVs, and ethanol to produce ethosomes. The structure and lamellar organization of the vesicle bilayer were investigated by transmission electron microscopy and small and wide angle X-ray scattering, as well as the main physico-chemical features. The formulations, along with a diclofenac solution and commercial Volta…

DiclofenacSurface PropertiesDrug CompoundingSkin AbsorptionLipid BilayersPharmaceutical ScienceIn Vitro TechniquesDermatitis ContactMiceDiclofenacMicroscopy Electron TransmissionX-Ray DiffractionmedicineAnimalsSkinDrug CarriersLiposomeChromatographyEthanolChemistryBilayerVesicleAnti-Inflammatory Agents Non-SteroidalDiclofenac SodiumPenetration (firestop)PermeationPropylene GlycolLiposomesBiophysicsNanoparticlesNanocarriersmedicine.drugInternational Journal of Pharmaceutics
researchProduct

New binary solid dispersion of indomethacin with surfactant polymer: From physical characterization to in vitro dissolution enhancement

2009

This article investigated preparation of solid dispersions containing a poor water-soluble drug, indomethacin (IND), and a new surfactant polymer, polyoxyethylene 32 distearate (POED). Solid dispersions were prepared by the melting method and characterized by DSC, hot-stage microscopy (HSM), X-ray diffraction (XRD) and scanning electron microscopy (SEM). DSC and HSM analyses performed on IND/POED physical mixtures indicated that IND could dissolve in liquid POED. The materials showed complete miscibility at liquid state. Combination of DSC, XRD, and SEM revealed that these materials had limited miscibility at the solid state. Up to 20% w/w IND in POED, we did not detect significant modifica…

Drug CarriersRecrystallization (geology)PolymersChemistryDrug CompoundingDrug StorageIndomethacinPharmaceutical ScienceMiscibilityPolyethylene GlycolsSurface-Active AgentsDifferential scanning calorimetryDrug StabilitySolubilityPulmonary surfactantChemical engineeringOrganic chemistryCrystalliteSolubilityCrystallizationDissolutionSolid solutionJournal of Pharmaceutical Sciences
researchProduct

Harmonic behavior of trehalose-coated carbon-monoxy-myoglobin at high temperature.

1999

Abstract Embedding biostructures in saccharide glasses protects them against extreme dehydration and/or exposure to very high temperature. Among the saccharides, trehalose appears to be the most effective bioprotectant. In this paper we report on the low-frequency dynamics of carbon monoxy myoglobin in an extremely dry trehalose glass measured by neutron spectroscopy. Under these conditions, the mean square displacements and the density of state function are those of a harmonic solid, up to room temperature, in contrast to D 2 O-hydrated myoglobin, in which a dynamical transition to a nonharmonic regime has been observed at ∼180K (Doster et al., 1989. Nature. 337:754–756). The protective ef…

Drug CompoundingBiophysicsAnalytical chemistrychemistry.chemical_elementTrappingchemistry.chemical_compoundmedicineScattering RadiationDehydrationDeuterium OxideCryopreservationNeutronsMyoglobinSpectrum AnalysisTemperatureTrehaloseWatermedicine.diseaseTrehaloseNeutron spectroscopyCrystallographychemistryMyoglobinHarmonicDensity of statesGlassCarbonResearch ArticleBiophysical journal
researchProduct

Recombinant cDNA encapsulation in small liposomes with hepatocyte access ability.

1993

Liposomal encapsulation efficiency of a recombinant cDNA was studied by several procedures. We observed that supernatant fraction of ultracentrifuged liposomes prepared by extrusion through polycarbonate filters of 400 nm pore size yielded a very homogeneous suspension of small (50 nm diameter) unilamellar liposomes with highest DNA/lipid ratio and great ability to access to hepatocytes.

Drug CompoundingDNA RecombinantPharmaceutical ScienceBioengineeringBiologyIn Vitro Techniqueslaw.inventionchemistry.chemical_compoundMiceColloid and Surface ChemistrylawComplementary DNAmedicineAnimalsHumansPhysical and Theoretical ChemistryFluoresceinParticle SizeLiposomeDrug CarriersChromatographyParaffin EmbeddingStaining and LabelingOrganic ChemistryFluoresceinsMice Inbred C57BLMicroscopy Electronmedicine.anatomical_structureBiochemistrychemistryLiverHepatocytealpha 1-AntitrypsinLiposomesRecombinant DNAExtrusionParticle sizeDrug carrierFiltrationPlasmidsJournal of microencapsulation
researchProduct

Loading, release and stability of epirubicin-loaded drug-eluting beads.

2015

Purpose The aim of this study was to determine the loading efficiency, physico-chemical stability and release of epirubicin-loaded DC Bead™ (Biocompatibles UK Ltd, a BTG International group company) (bead size 70–150 µm (=DC Bead M1™) and 100–300 µm) after loading with epirubicin solution (2 mg/ml) or reconstituted powder formulation (25 mg/ml) and controlled storage. Methods DC Bead™ were loaded with 76 mg epirubicin solution (Epimedac™, Medac GmbH) or 75 mg epirubicin powder formulation (Farmorubicin™, Pharmacia Pfizer GmbH) per 2 ml of beads. Drug loading efficiency and stability were determined by measuring the epirubicin concentration in the excess solution after predetermined interval…

Drug CompoundingDrug StorageBead030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineDrug StabilitymedicinePharmacology (medical)Particle SizeChromatography High Pressure LiquidEpirubicinDrug CarriersChromatographyAntibiotics AntineoplasticDrug eluting beadsElutionbusiness.industrySyringesMicrospheresOncology030220 oncology & carcinogenesisvisual_artDrug releasevisual_art.visual_art_mediumPowdersbusinessEpirubicinmedicine.drugJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
researchProduct